Conference Series llc LTD welcomes you to attend 2ndGlobal Congress on Asthma, Allergy and Immunology to speak on a theme “Innovative Studies on Immunity: To Control Asthma & Allergy” during September 18-19, 2019 Tokyo, Japan which is going to cover all aspects on scientific and technical advances in the field of medical science, environmental science and pharmaceutical science.
The main objective of the conference is to bring together leading academicians, scientists, researchers, graduate students and business delegates from the field of medical (Pulmonologists, Allergist /Immunologists), environmental specialist & pharmaceutical specialist and others from all over the world. Asthma Congress 2019 is a three days conference organized by Organizing Committee Members where it starts with a keynote session followed by oral presentation and poster presentations and final ends with the certificate distribution.
Conference Series llc LTD Organizes 1000+ Global Events inclusive of 300+ International Conferences, 500+ Workshops and 200+ Symposiums every year across USA- Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend?
In early days, asthma is considered only as a genetic disorder and allergy caused due to some natural triggers like dust, pollen, mold and roaches but the modern age has added several triggers (mainly environmental pollution like gases, fumes, smoking etc.), which cause asthma and allergic reaction. Eventhough our own immune system supports our body with antibodies; a regular exposure to environmental triggers at our job will surely cause asthma and allergic reaction. So we are inviting environmental research scholars with a research paper, to control the pollution and toxic substance and medical professionals, to come with a research article to cure asthma and allergy by increasing the immunity and also the pharmaceutical professionals, to come up with a new dosage form or new equipment to cure asthma and allergy.
Target Audience:
- Public Health Professional
- Immunologists
- Pulmonologists
- Allergist
- Pharmaceutical Professional
- Environmental Safety Professional